Philadelphia, PA (December 5, 2022) – MidLantic Urology has promoted Michael Hagg, M.D., to Market President. Market President is a key physician administrator for the organization who works with the Chief Operating Officer and other leadership in directing the organization's goals and objectives for improved clinical and operating performance. It is a newly created role at MidLantic Urology, the largest provider of urology services in Philadelphia. 

"Dr. Hagg is an established leader in our practice, currently serving as Chairman of the Board," said COO Jon Mackler. "We look forward to continued collaboration as he supports our group’s growth and advances our mission of delivering the highest standards of personalized patient care supported by clinical research."

Dr. Hagg has been a board-certified urologist since 2000. He sees patients at MidLantic Urology's Wynnewood and Broomall locations. Dr. Hagg completed medical school at Hahnemann University and his residency at the Hospital of the University of Pennsylvania. In addition to serving as Chairman of the Board for MidLantic Urology, he also serves as Chief of Urology for Main Line Health, on the executive committee of the Lankenau Oncologic Initiative, and assists as co-director for the American Cancer Society's Prostate Cancer Support Group at Lankenau Hospital.

About MidLantic Urology

MidLantic Urology is one of the country's largest and most innovative providers, combining top urology specialists with clinical research and state-of-the-art technology. The group has 70 physicians working in 47 locations throughout Philadelphia and surrounding counties, pioneering research and establishing nationally recognized centers of excellence focused on sub-specialties, including prostate cancer, kidney stones, and female pelvic medicine. To learn more about MidLantic Urology, visit midlanticurology.com.